Early Phase 1 Muscular Dystrophy Trial, Recruiting NCT06900049 Sponsor: Shanghai Jiao Tong University School of Medicine Condition: Muscular Dystrophy
Back to Muscular Dystrophy

Early Phase 1 Muscular Dystrophy Trial, Recruiting

NCT06900049
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The participant must be a boy between 4 and 8 years old (including those who are exactly 4 or 8) at the start of screening
  • The participant must have been diagnosed with Duchenne Muscular Dystrophy (DMD), a muscle-weakening condition, confirmed by genetic testing that shows their specific gene change can be targeted by a treatment approach called "exon 51 skipping" (confirm with trial site)
  • The participant and/or their parent or guardian must be willing to take part in the trial and able to understand and sign a consent form

Who may not be able to join:

  • Boys who show signs of heart failure, specifically where the heart is pumping less than 40% of its normal capacity
  • Boys whose lungs are working at less than 40% of the expected breathing capacity for someone their age and size
  • Boys whose heart electrical activity test (a standard heart tracing, called an ECG) shows a certain measurement called the QTc interval that is longer than 0.45 seconds, which can indicate a heart rhythm concern

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: +86 189 1661 3192

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Shanghai Jiao Tong University School of Medicine
Registry
ClinicalTrials.gov
Start date
24 October 2024
Est. completion
20 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Frequency of AEs, SAEs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov